Status:
COMPLETED
Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project
Lead Sponsor:
Samuel Merritt University
Conditions:
Cognitive Impairment, Mild
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: Many studies suggest physical activity reduces risk of dementia and improves global cognitive function in individuals with mild cognitive impairment (MCI). Using commercial wearable techno...
Eligibility Criteria
Inclusion
- Participants had a score of 0.5 on the Clinical Dementia Rating and are on a stable medication regimen for 3 months prior to enrollment.
Exclusion
- a diagnosis of dementia; receiving chemotherapy; unstable chronic diseases; surgery with general anesthesia in the prior 3 months; MRI-confirmed brain damage from trauma, stroke, or other neurological disorder; a myocardial infarction \< 1 year; a serious or non-healing wound, ulcer, or bone fracture; TUG ≥ 12 seconds; MoCA score \>26 or \<16; already using a wearable activity tracker; lacked access to the internet; or non-English speaking.
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04498195
Start Date
January 7 2019
End Date
December 6 2019
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sutter Medical Neuroscience
Sacramento, California, United States, 95816